Member Info for zebbo

at ridiculously low price.....

why not. This will just strengthen the research and speed things up. It will provide access to a plethora of Nano specialists.
I'm guessing that Medimmune may not have all the nano skills/knowledge required anyway

Great planning guys....full of BS exponential use of shareholder funds

I will switch the lights off on the way out

Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by "taking great ideas from the lab to the market"

Horizon 2020, (which has EUR 80 billion of funding available from 2014 – 2020), is building on those results with a focus on nanomedicine translation – helping innovation make it out of the lab and into healthcare provision. To help translate research into treatment, collaboration with industry is closer than ever. The private sector has increasing interest in stepping into the area of nanomedicine; the expected market share of final products is expected to be significant. In addition to the improved quality of health care, the creation of new jobs can be expected.

The EU has also established The European Technology Platform for Nanomedicine. This is an industry-led forum that provides input on the research priorities to be addressed and gives advice on innovation related policy for the nanomedicine field. Its members are European organisations that are actively researching the field of nanomedicine and working together to define research priorities and identify how best to get the results of research to patients.

Good reminder, these points are easy to overlook in the heat of SP volatility

The points Goldgirl raised are HIGHLY significant and are NOT REFLECTED in the current SP

Multiple news flows expected in Q4, this will rocket into double figures when news drops.
I did say we would stablise between 5.5 & 6.5 and am buying at current levels

looks like volumes have already slowed significantly move into the 5s imminent

Good comms and clarity around some of the topics that get misrepresented by punters who know jack s***, but think they are subject experts

I feel if we fail to advance tomorrow we will settle into a 5.5 - 6.5 range as volumes start to reduce and we await further news.

Will be buying more in the 5s given the opportunity

any advance

shes been pumped and now dumped........until next time

for those that have been spiked hang in there

is forecasting 15p in short order, as RNS is far from priced in. Any funding requirements have now been kicked into the long grass c2020

Does this mean we are in for SP volatility and what does this really mean for JOG

$N4P N4 Pharma’s Nuvec delivery system gets free shot in arm http://tinyurl.com/y8kfdazn via @proactive_UK @n4pharma #N4P #brighterir #AndrewScottTV #CapitalNetwork1

https://audioboom.com/posts/7016908-the-weekend-podcast?utm_campaign=detailpage&utm_content=retweet&utm_medium=social&utm_source=twitter

How much is Nuvec worth now ?
How much did the SP rise based Nuvec collaboration etc ?
What is the potential value after Q4 Nuvec update

One thing is for sure, its impossible to turn back time. For me the current SP looks v cheap for Nuvec alone. Hells bells we are ~4p, it can only go to 0 worst case, best case who knows....

risk reward is more than fair with just Nuvec. Lets not forget there anr may bio companies with massive mkt caps that only run with a single product

In fact I would say we are cheap based on progress.

No point bashing it now, you should have started at 30p....some people

Distressed sellers Im now picking some more up

Fillyerboots

think it has already tanked from 30p - 5p, or is that just a wild swing....lol

I actually feel more positive (strangely). We now have clear direction, some cash to progress Nuvec and who knows we could be back to 30p sooner than many think.

May pick up some more today and take advantage of the distress